21.20.Z - Manufacture of medicines and other pharmaceutical products
18 - Printing and reproduction of recorded media
21.10.Z - Manufacture of basic pharmaceutical substances
22 - Manufacture of rubber and plastic products
26 - Manufacture of computer, electronic and optical products
27 - Manufacture of electrical equipment
33 - Repair and installation of machinery and equipment
46 - Wholesale trade, except of motor vehicles and motorcycles
72 - Scientific research and development
77 - Rental and leasing activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 27,3 | 10,3 | 10 | -2,9 |
EBITDA | 39,9 | 20,9 | -0,1 | -100,7 |
Short time liabilities | 48,7 | 34,5 | 44,1 | 27,6 |
Equity capital | 122,6 | 130,7 | 138,6 | 6 |
Operating profit (EBIT) | 35,9 | 16,8 | -4,4 | -126,4 |
Assets | 173,9 | 170 | 187,4 | 10,2 |
Net profit (loss) | 21,9 | 8,1 | 7,8 | -3,3 |
Cash | 15,2 | 0,4 | 2,3 | 420,3 |
Net income from sale | 342,8 | 379,6 | 372,9 | -1,8 |
Liabilities and provisions for liabilities | 51,3 | 39,3 | 48,9 | 24,3 |
Working assets | 130,2 | 128 | 147 | 14,9 |
Depreciation | 3,9 | 4 | 4,3 | 6,3 |
% | % | % | p.p. | |
Profitability of capital | 17,9 | 6,2 | 5,7 | -0,5 |
Equity capital to total assets | 70,5 | 76,9 | 73,9 | -3 |
Gross profit margin | 8 | 2,7 | 2,7 | 0 |
EBITDA Margin | 11,6 | 5,5 | -0 | -5,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 52 | 33 | 43 | 10 |
Current financial liquidity indicator | 3.705261468887329 | 3.3355965614318848 | -0,4 | |
Net dept to EBITDA | 0.3100326657295227 | 9.817962646484375 | 9,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane